1. Home
  2. Live Updates
  3. Nalmefene

Nalmefene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nalmefene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nalmefene Today - Breaking & Trending Today

Newly approved overdose-reversal drug available in NH

Another tool has been approved in the fight against the opioid epidemic. ....

New Hampshire , United States , Ross Ketschke , Department Of Health , Human Services , New Hampshire The , Google Play , New Hampshire ,

New Hampshire expands access to nalmefene, a new opioid overdose reversal medication

“Nalmefene is emerging as one more tool at our disposal as we work to prevent opioid overdose deaths,” said DHHS Chief Medical Officer Jonathan Ballard. ....

New Hampshire , United States , State Opioid Response Grants , Opioid Antagonist , Standing Order , Food And Drug Administration , Opioid Overdose Deaths ,

New opioid reversal medication widely available in NH

The Department of Heath and Human Services announced pharmacies can start distributing Nalmefene to reverse the effects of an overdose ....

New Hampshire , United States , Jonathan Ballard , Human Services , Hampshire Department Of Health , New Hampshire Department , Medical Officer Jonathan ,

Oakland County Sheriff's Office first in U.S. to deploy Opvee nasal spray for opioid overdose reversal

There's a new nasal spray that reverses an opioid overdose. ....

Michael Bouchard , Steve Norris , Health Communities , Oakland County Health Network , Oakland County Sheriff Office , Alliance Of Coalitions , Oakland County Sheriff , County Sheriff Michael Bouchard , Nina De Lorenzo , Chief Global Impact Officer , Oakland County , Oakland County Health , Indivior Plc , United States , Opioid Epidemic In The United States , Medical Emergencies , State Government Response To The Opioid Epidemic In United States , Opioid Epidemic , Drug Overdose , Tertiary Alcohols , Opioid Overdose ,

Opiant Pharmaceuticals and Hikma announce exclusive $225 million commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK

LONDON, April 29, 2022 /PRNewswire/ Opiant Pharmaceutical UK. ("Opiant") and Hikma Pharmaceuticals PLC ("Hikma") today announced that they are entering into an exclusive license agreement ....

United States , United Kingdom , City Of , Ben Atkins , European Medicines Agency , Opiant Pharmaceuticals Inc , Hikma Pharmaceuticals , Pharmaceutical United , Roger Crystal , Chief Executive Officer , Opiant Pharmaceuticals , Middle East , North Africa ,